nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—CYP2D6—Hydroxyurea—head and neck cancer	0.165	0.399	CbGbCtD
Maprotiline—CYP1A2—Fluorouracil—head and neck cancer	0.0767	0.185	CbGbCtD
Maprotiline—ABCB1—Vinblastine—head and neck cancer	0.0621	0.15	CbGbCtD
Maprotiline—CYP2D6—Vinblastine—head and neck cancer	0.0585	0.141	CbGbCtD
Maprotiline—ABCB1—Docetaxel—head and neck cancer	0.0512	0.124	CbGbCtD
Maprotiline—HTR7—superior cervical ganglion—head and neck cancer	0.024	0.174	CbGeAlD
Maprotiline—Ileus paralytic—Vinblastine—head and neck cancer	0.0133	0.0353	CcSEcCtD
Maprotiline—HRH1—nose—head and neck cancer	0.0129	0.0936	CbGeAlD
Maprotiline—ORM1—saliva—head and neck cancer	0.0119	0.0863	CbGeAlD
Maprotiline—Inappropriate antidiuretic hormone secretion—Vinblastine—head and neck cancer	0.00993	0.0263	CcSEcCtD
Maprotiline—HTR7—cranial nerve—head and neck cancer	0.00968	0.0701	CbGeAlD
Maprotiline—HTR2A—trigeminal nerve—head and neck cancer	0.00847	0.0613	CbGeAlD
Maprotiline—Drug fever—Docetaxel—head and neck cancer	0.00819	0.0217	CcSEcCtD
Maprotiline—Bone marrow depression—Hydroxyurea—head and neck cancer	0.0078	0.0206	CcSEcCtD
Maprotiline—Numbness—Vinblastine—head and neck cancer	0.00696	0.0184	CcSEcCtD
Maprotiline—Sinus tachycardia—Docetaxel—head and neck cancer	0.00679	0.018	CcSEcCtD
Maprotiline—Sensory loss—Vinblastine—head and neck cancer	0.00666	0.0176	CcSEcCtD
Maprotiline—HTR2A—cranial nerve—head and neck cancer	0.00604	0.0437	CbGeAlD
Maprotiline—Interstitial pneumonia—Docetaxel—head and neck cancer	0.00566	0.015	CcSEcCtD
Maprotiline—Tingling sensation—Fluorouracil—head and neck cancer	0.00471	0.0125	CcSEcCtD
Maprotiline—CHRM3—exocrine gland—head and neck cancer	0.00458	0.0332	CbGeAlD
Maprotiline—Numbness—Fluorouracil—head and neck cancer	0.00457	0.0121	CcSEcCtD
Maprotiline—Sensory loss—Fluorouracil—head and neck cancer	0.00437	0.0116	CcSEcCtD
Maprotiline—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00427	0.0113	CcSEcCtD
Maprotiline—Disorientation—Hydroxyurea—head and neck cancer	0.00427	0.0113	CcSEcCtD
Maprotiline—Dysarthria—Fluorouracil—head and neck cancer	0.00401	0.0106	CcSEcCtD
Maprotiline—Interstitial lung disease—Docetaxel—head and neck cancer	0.00386	0.0102	CcSEcCtD
Maprotiline—Dermatitis atopic—Docetaxel—head and neck cancer	0.00369	0.00977	CcSEcCtD
Maprotiline—CHRM5—epithelium—head and neck cancer	0.00356	0.0258	CbGeAlD
Maprotiline—Breast disorder—Hydroxyurea—head and neck cancer	0.00345	0.00913	CcSEcCtD
Maprotiline—Pancytopenia—Vinblastine—head and neck cancer	0.00344	0.0091	CcSEcCtD
Maprotiline—HTR7—mouth—head and neck cancer	0.00326	0.0236	CbGeAlD
Maprotiline—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00318	0.00842	CcSEcCtD
Maprotiline—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00316	0.00837	CcSEcCtD
Maprotiline—Myocardial infarction—Vinblastine—head and neck cancer	0.00316	0.00837	CcSEcCtD
Maprotiline—Pancytopenia—Hydroxyurea—head and neck cancer	0.00314	0.0083	CcSEcCtD
Maprotiline—Disorientation—Fluorouracil—head and neck cancer	0.00307	0.00813	CcSEcCtD
Maprotiline—Bone disorder—Docetaxel—head and neck cancer	0.00303	0.00801	CcSEcCtD
Maprotiline—Agranulocytosis—Vinblastine—head and neck cancer	0.00301	0.00797	CcSEcCtD
Maprotiline—Weight increased—Hydroxyurea—head and neck cancer	0.00301	0.00795	CcSEcCtD
Maprotiline—Drowsiness—Hydroxyurea—head and neck cancer	0.00294	0.00779	CcSEcCtD
Maprotiline—Infestation NOS—Hydroxyurea—head and neck cancer	0.00294	0.00779	CcSEcCtD
Maprotiline—Infestation—Hydroxyurea—head and neck cancer	0.00294	0.00779	CcSEcCtD
Maprotiline—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00289	0.00764	CcSEcCtD
Maprotiline—Hypoaesthesia—Vinblastine—head and neck cancer	0.00288	0.00763	CcSEcCtD
Maprotiline—Stomatitis—Hydroxyurea—head and neck cancer	0.00287	0.00759	CcSEcCtD
Maprotiline—CHRM4—head—head and neck cancer	0.00283	0.0205	CbGeAlD
Maprotiline—HTR7—neck—head and neck cancer	0.00279	0.0202	CbGeAlD
Maprotiline—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00278	0.00737	CcSEcCtD
Maprotiline—Osteoarthritis—Fluorouracil—head and neck cancer	0.00275	0.00728	CcSEcCtD
Maprotiline—Blood pressure increased—Docetaxel—head and neck cancer	0.00273	0.00723	CcSEcCtD
Maprotiline—CHRM1—parotid gland—head and neck cancer	0.00266	0.0193	CbGeAlD
Maprotiline—Hallucination—Hydroxyurea—head and neck cancer	0.00263	0.00696	CcSEcCtD
Maprotiline—Ataxia—Fluorouracil—head and neck cancer	0.00259	0.00684	CcSEcCtD
Maprotiline—Alopecia—Vinblastine—head and neck cancer	0.00256	0.00678	CcSEcCtD
Maprotiline—CHRM1—saliva-secreting gland—head and neck cancer	0.00255	0.0185	CbGeAlD
Maprotiline—Muscular weakness—Fluorouracil—head and neck cancer	0.00243	0.00642	CcSEcCtD
Maprotiline—Angiopathy—Hydroxyurea—head and neck cancer	0.0024	0.00634	CcSEcCtD
Maprotiline—Dysphagia—Fluorouracil—head and neck cancer	0.00238	0.00629	CcSEcCtD
Maprotiline—Eosinophilia—Fluorouracil—head and neck cancer	0.00235	0.00623	CcSEcCtD
Maprotiline—Alopecia—Hydroxyurea—head and neck cancer	0.00234	0.00618	CcSEcCtD
Maprotiline—CHRM3—saliva-secreting gland—head and neck cancer	0.00228	0.0165	CbGeAlD
Maprotiline—Leukopenia—Vinblastine—head and neck cancer	0.00226	0.00598	CcSEcCtD
Maprotiline—Pancytopenia—Fluorouracil—head and neck cancer	0.00226	0.00597	CcSEcCtD
Maprotiline—CHRM5—head—head and neck cancer	0.00221	0.016	CbGeAlD
Maprotiline—Convulsion—Vinblastine—head and neck cancer	0.00219	0.00578	CcSEcCtD
Maprotiline—Hypertension—Vinblastine—head and neck cancer	0.00218	0.00576	CcSEcCtD
Maprotiline—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00217	0.00574	CcSEcCtD
Maprotiline—Hot flush—Docetaxel—head and neck cancer	0.00212	0.00561	CcSEcCtD
Maprotiline—Infestation—Fluorouracil—head and neck cancer	0.00212	0.00561	CcSEcCtD
Maprotiline—Infestation NOS—Fluorouracil—head and neck cancer	0.00212	0.00561	CcSEcCtD
Maprotiline—Menopausal symptoms—Docetaxel—head and neck cancer	0.0021	0.00557	CcSEcCtD
Maprotiline—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00209	0.00553	CcSEcCtD
Maprotiline—Myocardial infarction—Fluorouracil—head and neck cancer	0.00208	0.0055	CcSEcCtD
Maprotiline—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00208	0.0055	CcSEcCtD
Maprotiline—Stomatitis—Fluorouracil—head and neck cancer	0.00207	0.00547	CcSEcCtD
Maprotiline—Leukopenia—Hydroxyurea—head and neck cancer	0.00206	0.00545	CcSEcCtD
Maprotiline—Thrombocytopenia—Vinblastine—head and neck cancer	0.00202	0.00533	CcSEcCtD
Maprotiline—HTR7—connective tissue—head and neck cancer	0.002	0.0145	CbGeAlD
Maprotiline—Convulsion—Hydroxyurea—head and neck cancer	0.00199	0.00527	CcSEcCtD
Maprotiline—Agranulocytosis—Fluorouracil—head and neck cancer	0.00198	0.00523	CcSEcCtD
Maprotiline—CHRM1—trachea—head and neck cancer	0.00197	0.0143	CbGeAlD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00195	0.00515	CcSEcCtD
Maprotiline—HTR7—epithelium—head and neck cancer	0.0019	0.0137	CbGeAlD
Maprotiline—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00189	0.00501	CcSEcCtD
Maprotiline—Oedema—Hydroxyurea—head and neck cancer	0.00188	0.00497	CcSEcCtD
Maprotiline—Ataxia—Docetaxel—head and neck cancer	0.00187	0.00494	CcSEcCtD
Maprotiline—Infection—Hydroxyurea—head and neck cancer	0.00187	0.00494	CcSEcCtD
Maprotiline—Paraesthesia—Vinblastine—head and neck cancer	0.00185	0.00489	CcSEcCtD
Maprotiline—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00184	0.00487	CcSEcCtD
Maprotiline—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00184	0.00486	CcSEcCtD
Maprotiline—Liver function test abnormal—Docetaxel—head and neck cancer	0.00183	0.00485	CcSEcCtD
Maprotiline—Skin disorder—Hydroxyurea—head and neck cancer	0.00182	0.00483	CcSEcCtD
Maprotiline—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00181	0.0048	CcSEcCtD
Maprotiline—Breast disorder—Docetaxel—head and neck cancer	0.00179	0.00475	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00179	0.00473	CcSEcCtD
Maprotiline—Constipation—Vinblastine—head and neck cancer	0.00176	0.00466	CcSEcCtD
Maprotiline—HTR2A—neck—head and neck cancer	0.00174	0.0126	CbGeAlD
Maprotiline—Dysphagia—Docetaxel—head and neck cancer	0.00172	0.00454	CcSEcCtD
Maprotiline—Arrhythmia—Fluorouracil—head and neck cancer	0.0017	0.0045	CcSEcCtD
Maprotiline—Feeling abnormal—Vinblastine—head and neck cancer	0.0017	0.00449	CcSEcCtD
Maprotiline—Bronchospasm—Docetaxel—head and neck cancer	0.00169	0.00446	CcSEcCtD
Maprotiline—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00168	0.00445	CcSEcCtD
Maprotiline—Alopecia—Fluorouracil—head and neck cancer	0.00168	0.00445	CcSEcCtD
Maprotiline—HTR7—trachea—head and neck cancer	0.00168	0.0121	CbGeAlD
Maprotiline—Somnolence—Hydroxyurea—head and neck cancer	0.00167	0.00442	CcSEcCtD
Maprotiline—Dyspepsia—Hydroxyurea—head and neck cancer	0.00165	0.00437	CcSEcCtD
Maprotiline—Pancytopenia—Docetaxel—head and neck cancer	0.00163	0.00431	CcSEcCtD
Maprotiline—Abdominal pain—Vinblastine—head and neck cancer	0.00163	0.00431	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00162	0.00429	CcSEcCtD
Maprotiline—Fatigue—Hydroxyurea—head and neck cancer	0.00162	0.00428	CcSEcCtD
Maprotiline—Constipation—Hydroxyurea—head and neck cancer	0.00161	0.00425	CcSEcCtD
Maprotiline—Weight increased—Docetaxel—head and neck cancer	0.00156	0.00413	CcSEcCtD
Maprotiline—Vision blurred—Fluorouracil—head and neck cancer	0.00156	0.00413	CcSEcCtD
Maprotiline—Weight decreased—Docetaxel—head and neck cancer	0.00155	0.00411	CcSEcCtD
Maprotiline—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00155	0.00409	CcSEcCtD
Maprotiline—Infestation NOS—Docetaxel—head and neck cancer	0.00153	0.00405	CcSEcCtD
Maprotiline—Infestation—Docetaxel—head and neck cancer	0.00153	0.00405	CcSEcCtD
Maprotiline—CHRM2—head—head and neck cancer	0.00152	0.011	CbGeAlD
Maprotiline—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00152	0.00401	CcSEcCtD
Maprotiline—SLC6A3—head—head and neck cancer	0.00151	0.011	CbGeAlD
Maprotiline—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00151	0.00399	CcSEcCtD
Maprotiline—Myocardial infarction—Docetaxel—head and neck cancer	0.0015	0.00397	CcSEcCtD
Maprotiline—Neuropathy peripheral—Docetaxel—head and neck cancer	0.0015	0.00397	CcSEcCtD
Maprotiline—HRH1—connective tissue—head and neck cancer	0.00149	0.0108	CbGeAlD
Maprotiline—Stomatitis—Docetaxel—head and neck cancer	0.00149	0.00394	CcSEcCtD
Maprotiline—Jaundice—Docetaxel—head and neck cancer	0.00149	0.00394	CcSEcCtD
Maprotiline—Body temperature increased—Hydroxyurea—head and neck cancer	0.00148	0.00393	CcSEcCtD
Maprotiline—Leukopenia—Fluorouracil—head and neck cancer	0.00148	0.00392	CcSEcCtD
Maprotiline—Asthenia—Vinblastine—head and neck cancer	0.00148	0.00391	CcSEcCtD
Maprotiline—HTR2C—head—head and neck cancer	0.00146	0.0106	CbGeAlD
Maprotiline—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00145	0.00383	CcSEcCtD
Maprotiline—Convulsion—Fluorouracil—head and neck cancer	0.00143	0.0038	CcSEcCtD
Maprotiline—Agranulocytosis—Docetaxel—head and neck cancer	0.00143	0.00378	CcSEcCtD
Maprotiline—HRH1—epithelium—head and neck cancer	0.00142	0.0103	CbGeAlD
Maprotiline—Diarrhoea—Vinblastine—head and neck cancer	0.00141	0.00373	CcSEcCtD
Maprotiline—CHRM3—thyroid gland—head and neck cancer	0.00139	0.0101	CbGeAlD
Maprotiline—CHRM1—head—head and neck cancer	0.00138	0.01	CbGeAlD
Maprotiline—Hepatitis—Docetaxel—head and neck cancer	0.00137	0.00363	CcSEcCtD
Maprotiline—Hypoaesthesia—Docetaxel—head and neck cancer	0.00137	0.00361	CcSEcCtD
Maprotiline—Confusional state—Fluorouracil—head and neck cancer	0.00136	0.00361	CcSEcCtD
Maprotiline—Dizziness—Vinblastine—head and neck cancer	0.00136	0.0036	CcSEcCtD
Maprotiline—Urinary tract disorder—Docetaxel—head and neck cancer	0.00136	0.00359	CcSEcCtD
Maprotiline—Oedema—Fluorouracil—head and neck cancer	0.00135	0.00358	CcSEcCtD
Maprotiline—Asthenia—Hydroxyurea—head and neck cancer	0.00135	0.00356	CcSEcCtD
Maprotiline—Urethral disorder—Docetaxel—head and neck cancer	0.00135	0.00356	CcSEcCtD
Maprotiline—Infection—Fluorouracil—head and neck cancer	0.00134	0.00355	CcSEcCtD
Maprotiline—Nervous system disorder—Fluorouracil—head and neck cancer	0.00133	0.00351	CcSEcCtD
Maprotiline—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00132	0.0035	CcSEcCtD
Maprotiline—Tachycardia—Fluorouracil—head and neck cancer	0.00132	0.00349	CcSEcCtD
Maprotiline—Vomiting—Vinblastine—head and neck cancer	0.00131	0.00346	CcSEcCtD
Maprotiline—Erythema multiforme—Docetaxel—head and neck cancer	0.0013	0.00344	CcSEcCtD
Maprotiline—Headache—Vinblastine—head and neck cancer	0.00129	0.00341	CcSEcCtD
Maprotiline—Diarrhoea—Hydroxyurea—head and neck cancer	0.00128	0.0034	CcSEcCtD
Maprotiline—Eye disorder—Docetaxel—head and neck cancer	0.00128	0.0034	CcSEcCtD
Maprotiline—Cardiac disorder—Docetaxel—head and neck cancer	0.00127	0.00337	CcSEcCtD
Maprotiline—Flushing—Docetaxel—head and neck cancer	0.00127	0.00337	CcSEcCtD
Maprotiline—Hypotension—Fluorouracil—head and neck cancer	0.00126	0.00334	CcSEcCtD
Maprotiline—HRH1—trachea—head and neck cancer	0.00125	0.00906	CbGeAlD
Maprotiline—Angiopathy—Docetaxel—head and neck cancer	0.00125	0.0033	CcSEcCtD
Maprotiline—HTR2A—connective tissue—head and neck cancer	0.00125	0.00902	CbGeAlD
Maprotiline—Dizziness—Hydroxyurea—head and neck cancer	0.00124	0.00329	CcSEcCtD
Maprotiline—Mediastinal disorder—Docetaxel—head and neck cancer	0.00124	0.00327	CcSEcCtD
Maprotiline—CHRM3—head—head and neck cancer	0.00124	0.00895	CbGeAlD
Maprotiline—Arrhythmia—Docetaxel—head and neck cancer	0.00123	0.00325	CcSEcCtD
Maprotiline—Nausea—Vinblastine—head and neck cancer	0.00122	0.00324	CcSEcCtD
Maprotiline—Insomnia—Fluorouracil—head and neck cancer	0.00122	0.00323	CcSEcCtD
Maprotiline—SLC6A2—head—head and neck cancer	0.00122	0.00884	CbGeAlD
Maprotiline—Paraesthesia—Fluorouracil—head and neck cancer	0.00121	0.00321	CcSEcCtD
Maprotiline—Alopecia—Docetaxel—head and neck cancer	0.00121	0.00321	CcSEcCtD
Maprotiline—Somnolence—Fluorouracil—head and neck cancer	0.0012	0.00318	CcSEcCtD
Maprotiline—Malnutrition—Docetaxel—head and neck cancer	0.0012	0.00316	CcSEcCtD
Maprotiline—Vomiting—Hydroxyurea—head and neck cancer	0.00119	0.00316	CcSEcCtD
Maprotiline—Dyspepsia—Fluorouracil—head and neck cancer	0.00119	0.00315	CcSEcCtD
Maprotiline—Rash—Hydroxyurea—head and neck cancer	0.00118	0.00313	CcSEcCtD
Maprotiline—Dermatitis—Hydroxyurea—head and neck cancer	0.00118	0.00313	CcSEcCtD
Maprotiline—HTR2A—epithelium—head and neck cancer	0.00118	0.00856	CbGeAlD
Maprotiline—HTR7—head—head and neck cancer	0.00118	0.00852	CbGeAlD
Maprotiline—Headache—Hydroxyurea—head and neck cancer	0.00118	0.00311	CcSEcCtD
Maprotiline—Dysgeusia—Docetaxel—head and neck cancer	0.00117	0.0031	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00117	0.00309	CcSEcCtD
Maprotiline—ORM1—lymph node—head and neck cancer	0.00114	0.00825	CbGeAlD
Maprotiline—Nausea—Hydroxyurea—head and neck cancer	0.00112	0.00295	CcSEcCtD
Maprotiline—Feeling abnormal—Fluorouracil—head and neck cancer	0.00111	0.00295	CcSEcCtD
Maprotiline—DRD2—head—head and neck cancer	0.00111	0.00806	CbGeAlD
Maprotiline—Urticaria—Fluorouracil—head and neck cancer	0.00107	0.00284	CcSEcCtD
Maprotiline—Syncope—Docetaxel—head and neck cancer	0.00107	0.00284	CcSEcCtD
Maprotiline—Leukopenia—Docetaxel—head and neck cancer	0.00107	0.00283	CcSEcCtD
Maprotiline—Body temperature increased—Fluorouracil—head and neck cancer	0.00107	0.00283	CcSEcCtD
Maprotiline—CYP1A2—thyroid gland—head and neck cancer	0.00106	0.00766	CbGeAlD
Maprotiline—Palpitations—Docetaxel—head and neck cancer	0.00106	0.00279	CcSEcCtD
Maprotiline—Loss of consciousness—Docetaxel—head and neck cancer	0.00105	0.00278	CcSEcCtD
Maprotiline—HTR2A—trachea—head and neck cancer	0.00105	0.00757	CbGeAlD
Maprotiline—Convulsion—Docetaxel—head and neck cancer	0.00104	0.00274	CcSEcCtD
Maprotiline—Hypertension—Docetaxel—head and neck cancer	0.00103	0.00273	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00101	0.00267	CcSEcCtD
Maprotiline—Dry mouth—Docetaxel—head and neck cancer	0.000995	0.00263	CcSEcCtD
Maprotiline—Confusional state—Docetaxel—head and neck cancer	0.000984	0.0026	CcSEcCtD
Maprotiline—Oedema—Docetaxel—head and neck cancer	0.000976	0.00258	CcSEcCtD
Maprotiline—Infection—Docetaxel—head and neck cancer	0.000969	0.00256	CcSEcCtD
Maprotiline—Shock—Docetaxel—head and neck cancer	0.00096	0.00254	CcSEcCtD
Maprotiline—Nervous system disorder—Docetaxel—head and neck cancer	0.000957	0.00253	CcSEcCtD
Maprotiline—Pruritus—Fluorouracil—head and neck cancer	0.000956	0.00253	CcSEcCtD
Maprotiline—Thrombocytopenia—Docetaxel—head and neck cancer	0.000955	0.00253	CcSEcCtD
Maprotiline—Tachycardia—Docetaxel—head and neck cancer	0.000952	0.00252	CcSEcCtD
Maprotiline—Skin disorder—Docetaxel—head and neck cancer	0.000948	0.00251	CcSEcCtD
Maprotiline—Diarrhoea—Fluorouracil—head and neck cancer	0.000925	0.00245	CcSEcCtD
Maprotiline—Hypotension—Docetaxel—head and neck cancer	0.000912	0.00241	CcSEcCtD
Maprotiline—Dizziness—Fluorouracil—head and neck cancer	0.000894	0.00236	CcSEcCtD
Maprotiline—Insomnia—Docetaxel—head and neck cancer	0.000882	0.00233	CcSEcCtD
Maprotiline—HRH1—head—head and neck cancer	0.000879	0.00636	CbGeAlD
Maprotiline—Paraesthesia—Docetaxel—head and neck cancer	0.000876	0.00232	CcSEcCtD
Maprotiline—Somnolence—Docetaxel—head and neck cancer	0.000867	0.00229	CcSEcCtD
Maprotiline—Vomiting—Fluorouracil—head and neck cancer	0.000859	0.00227	CcSEcCtD
Maprotiline—Dyspepsia—Docetaxel—head and neck cancer	0.000859	0.00227	CcSEcCtD
Maprotiline—SLC6A2—lymph node—head and neck cancer	0.000855	0.00619	CbGeAlD
Maprotiline—Rash—Fluorouracil—head and neck cancer	0.000852	0.00225	CcSEcCtD
Maprotiline—Dermatitis—Fluorouracil—head and neck cancer	0.000851	0.00225	CcSEcCtD
Maprotiline—Headache—Fluorouracil—head and neck cancer	0.000847	0.00224	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000842	0.00223	CcSEcCtD
Maprotiline—Fatigue—Docetaxel—head and neck cancer	0.000841	0.00223	CcSEcCtD
Maprotiline—Constipation—Docetaxel—head and neck cancer	0.000834	0.00221	CcSEcCtD
Maprotiline—Feeling abnormal—Docetaxel—head and neck cancer	0.000804	0.00213	CcSEcCtD
Maprotiline—Nausea—Fluorouracil—head and neck cancer	0.000803	0.00212	CcSEcCtD
Maprotiline—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000798	0.00211	CcSEcCtD
Maprotiline—ABCB1—epithelium—head and neck cancer	0.000775	0.00561	CbGeAlD
Maprotiline—Abdominal pain—Docetaxel—head and neck cancer	0.000771	0.00204	CcSEcCtD
Maprotiline—Body temperature increased—Docetaxel—head and neck cancer	0.000771	0.00204	CcSEcCtD
Maprotiline—HTR2A—head—head and neck cancer	0.000734	0.00531	CbGeAlD
Maprotiline—Asthenia—Docetaxel—head and neck cancer	0.0007	0.00185	CcSEcCtD
Maprotiline—Pruritus—Docetaxel—head and neck cancer	0.00069	0.00183	CcSEcCtD
Maprotiline—ABCB1—trachea—head and neck cancer	0.000685	0.00496	CbGeAlD
Maprotiline—CYP2D6—head—head and neck cancer	0.000669	0.00484	CbGeAlD
Maprotiline—Diarrhoea—Docetaxel—head and neck cancer	0.000667	0.00177	CcSEcCtD
Maprotiline—Dizziness—Docetaxel—head and neck cancer	0.000645	0.00171	CcSEcCtD
Maprotiline—Vomiting—Docetaxel—head and neck cancer	0.00062	0.00164	CcSEcCtD
Maprotiline—HRH1—lymph node—head and neck cancer	0.000615	0.00445	CbGeAlD
Maprotiline—Rash—Docetaxel—head and neck cancer	0.000615	0.00163	CcSEcCtD
Maprotiline—Dermatitis—Docetaxel—head and neck cancer	0.000615	0.00163	CcSEcCtD
Maprotiline—Headache—Docetaxel—head and neck cancer	0.000611	0.00162	CcSEcCtD
Maprotiline—ABCB1—lymphoid tissue—head and neck cancer	0.000597	0.00432	CbGeAlD
Maprotiline—Nausea—Docetaxel—head and neck cancer	0.000579	0.00153	CcSEcCtD
Maprotiline—ABCB1—thyroid gland—head and neck cancer	0.000542	0.00392	CbGeAlD
Maprotiline—ABCB1—head—head and neck cancer	0.000481	0.00348	CbGeAlD
Maprotiline—ABCB1—lymph node—head and neck cancer	0.000337	0.00244	CbGeAlD
Maprotiline—HTR7—Signaling by GPCR—EGFR—head and neck cancer	2.78e-05	0.000399	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—MAPK3—head and neck cancer	2.76e-05	0.000396	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL2—head and neck cancer	2.68e-05	0.000385	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—YAP1—head and neck cancer	2.67e-05	0.000382	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—PIK3CA—head and neck cancer	2.66e-05	0.000381	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—MAPK3—head and neck cancer	2.65e-05	0.000379	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—MAPK1—head and neck cancer	2.63e-05	0.000377	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—EGFR—head and neck cancer	2.63e-05	0.000377	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—IL2—head and neck cancer	2.61e-05	0.000374	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—IL2—head and neck cancer	2.57e-05	0.000368	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—IL2—head and neck cancer	2.56e-05	0.000367	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—IL2—head and neck cancer	2.55e-05	0.000366	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—IL2—head and neck cancer	2.55e-05	0.000365	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—IL2—head and neck cancer	2.52e-05	0.000361	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—MAPK1—head and neck cancer	2.52e-05	0.000361	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—EGFR—head and neck cancer	2.52e-05	0.000361	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—PIK3CA—head and neck cancer	2.51e-05	0.00036	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—PIK3CA—head and neck cancer	2.42e-05	0.000346	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—PIK3CA—head and neck cancer	2.41e-05	0.000345	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL2—head and neck cancer	2.37e-05	0.000339	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL2—head and neck cancer	2.33e-05	0.000334	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL2—head and neck cancer	2.33e-05	0.000333	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL2—head and neck cancer	2.32e-05	0.000332	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL2—head and neck cancer	2.31e-05	0.000331	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NOTCH1—head and neck cancer	2.3e-05	0.00033	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL2—head and neck cancer	2.29e-05	0.000328	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—PIK3CA—head and neck cancer	2.28e-05	0.000327	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—HRAS—head and neck cancer	2.24e-05	0.00032	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—PIK3CA—head and neck cancer	2.19e-05	0.000313	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—AKT1—head and neck cancer	2.17e-05	0.000312	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—MAPK3—head and neck cancer	2.16e-05	0.000309	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL2—head and neck cancer	2.15e-05	0.000308	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—HRAS—head and neck cancer	2.11e-05	0.000303	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CCND1—head and neck cancer	2.1e-05	0.0003	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—MAPK1—head and neck cancer	2.05e-05	0.000294	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—AKT1—head and neck cancer	2.05e-05	0.000294	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—EGFR—head and neck cancer	2.05e-05	0.000294	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NOTCH1—head and neck cancer	2.03e-05	0.000291	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL2—head and neck cancer	2.03e-05	0.000291	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—PTEN—head and neck cancer	2.02e-05	0.00029	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—HRAS—head and neck cancer	2.02e-05	0.00029	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—TYMS—head and neck cancer	2.01e-05	0.000287	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2e-05	0.000287	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NOTCH1—head and neck cancer	2e-05	0.000287	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NOTCH1—head and neck cancer	2e-05	0.000286	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NOTCH1—head and neck cancer	1.99e-05	0.000285	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NOTCH1—head and neck cancer	1.98e-05	0.000284	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GSTM1—head and neck cancer	1.98e-05	0.000284	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CCND1—head and neck cancer	1.98e-05	0.000284	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—AKT1—head and neck cancer	1.97e-05	0.000283	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—AKT1—head and neck cancer	1.97e-05	0.000282	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NOTCH1—head and neck cancer	1.96e-05	0.000281	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—PIK3CA—head and neck cancer	1.96e-05	0.000281	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL2—head and neck cancer	1.95e-05	0.000279	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—PTEN—head and neck cancer	1.91e-05	0.000274	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—MAPK3—head and neck cancer	1.9e-05	0.000273	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GPX1—head and neck cancer	1.9e-05	0.000272	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CCND1—head and neck cancer	1.9e-05	0.000272	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—TYMS—head and neck cancer	1.89e-05	0.000271	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.88e-05	0.000269	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—MAPK3—head and neck cancer	1.87e-05	0.000269	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—MAPK3—head and neck cancer	1.87e-05	0.000268	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.87e-05	0.000268	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—AKT1—head and neck cancer	1.86e-05	0.000267	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—MAPK3—head and neck cancer	1.86e-05	0.000267	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—MAPK3—head and neck cancer	1.86e-05	0.000266	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—MAPK3—head and neck cancer	1.84e-05	0.000264	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—PTEN—head and neck cancer	1.83e-05	0.000262	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—VEGFA—head and neck cancer	1.83e-05	0.000262	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—MAPK1—head and neck cancer	1.81e-05	0.00026	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—EGFR—head and neck cancer	1.81e-05	0.00026	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—STAT3—head and neck cancer	1.81e-05	0.000259	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GPX1—head and neck cancer	1.79e-05	0.000256	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—AKT1—head and neck cancer	1.79e-05	0.000256	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—MAPK1—head and neck cancer	1.78e-05	0.000255	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—EGFR—head and neck cancer	1.78e-05	0.000255	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—PIK3CA—head and neck cancer	1.78e-05	0.000255	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—MAPK1—head and neck cancer	1.78e-05	0.000255	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—EGFR—head and neck cancer	1.78e-05	0.000255	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—MAPK1—head and neck cancer	1.77e-05	0.000254	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—EGFR—head and neck cancer	1.77e-05	0.000254	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.77e-05	0.000254	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—MAPK1—head and neck cancer	1.77e-05	0.000253	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—EGFR—head and neck cancer	1.77e-05	0.000253	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PTGS2—head and neck cancer	1.76e-05	0.000252	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—MAPK1—head and neck cancer	1.75e-05	0.000251	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—EGFR—head and neck cancer	1.75e-05	0.000251	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.75e-05	0.00025	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—PIK3CA—head and neck cancer	1.73e-05	0.000248	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MAPK3—head and neck cancer	1.73e-05	0.000248	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—VEGFA—head and neck cancer	1.73e-05	0.000247	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—STAT3—head and neck cancer	1.71e-05	0.000245	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—PIK3CA—head and neck cancer	1.7e-05	0.000244	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—PIK3CA—head and neck cancer	1.7e-05	0.000244	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—PIK3CA—head and neck cancer	1.69e-05	0.000243	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—PIK3CA—head and neck cancer	1.69e-05	0.000242	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—PIK3CA—head and neck cancer	1.67e-05	0.00024	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—VEGFA—head and neck cancer	1.65e-05	0.000237	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—HRAS—head and neck cancer	1.65e-05	0.000236	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MAPK1—head and neck cancer	1.65e-05	0.000236	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—EGFR—head and neck cancer	1.65e-05	0.000236	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—STAT3—head and neck cancer	1.64e-05	0.000235	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MAPK3—head and neck cancer	1.63e-05	0.000234	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—AKT1—head and neck cancer	1.6e-05	0.00023	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—TYMS—head and neck cancer	1.6e-05	0.000229	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL2—head and neck cancer	1.59e-05	0.000227	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.58e-05	0.000227	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—PIK3CA—head and neck cancer	1.57e-05	0.000225	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MAPK3—head and neck cancer	1.56e-05	0.000224	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MAPK1—head and neck cancer	1.55e-05	0.000223	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—EGFR—head and neck cancer	1.55e-05	0.000223	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—PIK3CA—head and neck cancer	1.55e-05	0.000222	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CCND1—head and neck cancer	1.55e-05	0.000221	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—PIK3CA—head and neck cancer	1.54e-05	0.000221	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—PIK3CA—head and neck cancer	1.54e-05	0.000221	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PTEN—head and neck cancer	1.54e-05	0.00022	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—PIK3CA—head and neck cancer	1.53e-05	0.00022	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—PIK3CA—head and neck cancer	1.52e-05	0.000218	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GPX1—head and neck cancer	1.52e-05	0.000217	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.5e-05	0.000215	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—PTEN—head and neck cancer	1.49e-05	0.000214	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MAPK1—head and neck cancer	1.49e-05	0.000213	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—EGFR—head and neck cancer	1.49e-05	0.000213	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—AKT1—head and neck cancer	1.46e-05	0.000209	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—HRAS—head and neck cancer	1.45e-05	0.000208	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—HRAS—head and neck cancer	1.43e-05	0.000205	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—HRAS—head and neck cancer	1.43e-05	0.000205	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—PIK3CA—head and neck cancer	1.43e-05	0.000205	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—HRAS—head and neck cancer	1.42e-05	0.000204	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—HRAS—head and neck cancer	1.42e-05	0.000203	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—AKT1—head and neck cancer	1.41e-05	0.000203	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—HRAS—head and neck cancer	1.41e-05	0.000201	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL2—head and neck cancer	1.4e-05	0.000201	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—AKT1—head and neck cancer	1.39e-05	0.000199	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—AKT1—head and neck cancer	1.39e-05	0.000199	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—AKT1—head and neck cancer	1.38e-05	0.000198	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TP53—head and neck cancer	1.38e-05	0.000198	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—AKT1—head and neck cancer	1.38e-05	0.000198	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL2—head and neck cancer	1.38e-05	0.000197	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL2—head and neck cancer	1.37e-05	0.000197	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL2—head and neck cancer	1.37e-05	0.000196	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—AKT1—head and neck cancer	1.37e-05	0.000196	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL2—head and neck cancer	1.37e-05	0.000196	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCND1—head and neck cancer	1.36e-05	0.000195	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL2—head and neck cancer	1.35e-05	0.000194	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—PIK3CA—head and neck cancer	1.35e-05	0.000193	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—VEGFA—head and neck cancer	1.35e-05	0.000193	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCND1—head and neck cancer	1.34e-05	0.000192	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCND1—head and neck cancer	1.34e-05	0.000192	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCND1—head and neck cancer	1.34e-05	0.000191	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—STAT3—head and neck cancer	1.33e-05	0.000191	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCND1—head and neck cancer	1.33e-05	0.000191	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—HRAS—head and neck cancer	1.32e-05	0.000189	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCND1—head and neck cancer	1.32e-05	0.000189	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PTEN—head and neck cancer	1.32e-05	0.000189	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TP53—head and neck cancer	1.3e-05	0.000187	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PTEN—head and neck cancer	1.3e-05	0.000186	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PTEN—head and neck cancer	1.29e-05	0.000185	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—PIK3CA—head and neck cancer	1.29e-05	0.000185	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PTEN—head and neck cancer	1.29e-05	0.000185	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—AKT1—head and neck cancer	1.28e-05	0.000184	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PTEN—head and neck cancer	1.28e-05	0.000184	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MAPK3—head and neck cancer	1.27e-05	0.000183	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PTEN—head and neck cancer	1.27e-05	0.000182	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—AKT1—head and neck cancer	1.26e-05	0.000181	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—AKT1—head and neck cancer	1.26e-05	0.000181	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—AKT1—head and neck cancer	1.26e-05	0.00018	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—AKT1—head and neck cancer	1.25e-05	0.00018	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TP53—head and neck cancer	1.25e-05	0.000179	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—HRAS—head and neck cancer	1.25e-05	0.000179	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—AKT1—head and neck cancer	1.24e-05	0.000178	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.23e-05	0.000177	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MAPK1—head and neck cancer	1.21e-05	0.000174	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—EGFR—head and neck cancer	1.21e-05	0.000174	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—HRAS—head and neck cancer	1.19e-05	0.000171	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—VEGFA—head and neck cancer	1.19e-05	0.00017	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—STAT3—head and neck cancer	1.18e-05	0.000169	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—VEGFA—head and neck cancer	1.17e-05	0.000168	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—VEGFA—head and neck cancer	1.17e-05	0.000167	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—AKT1—head and neck cancer	1.17e-05	0.000167	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—VEGFA—head and neck cancer	1.16e-05	0.000167	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—VEGFA—head and neck cancer	1.16e-05	0.000166	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—STAT3—head and neck cancer	1.16e-05	0.000166	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—STAT3—head and neck cancer	1.16e-05	0.000166	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—STAT3—head and neck cancer	1.15e-05	0.000165	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—VEGFA—head and neck cancer	1.15e-05	0.000165	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—STAT3—head and neck cancer	1.15e-05	0.000165	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—STAT3—head and neck cancer	1.14e-05	0.000163	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MAPK3—head and neck cancer	1.13e-05	0.000161	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PTGS2—head and neck cancer	1.12e-05	0.00016	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MAPK3—head and neck cancer	1.11e-05	0.000159	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MAPK3—head and neck cancer	1.1e-05	0.000158	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—AKT1—head and neck cancer	1.1e-05	0.000158	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MAPK3—head and neck cancer	1.1e-05	0.000158	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MAPK3—head and neck cancer	1.1e-05	0.000157	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MAPK3—head and neck cancer	1.09e-05	0.000156	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PIK3CA—head and neck cancer	1.08e-05	0.000155	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MAPK1—head and neck cancer	1.07e-05	0.000153	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—EGFR—head and neck cancer	1.07e-05	0.000153	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—AKT1—head and neck cancer	1.05e-05	0.000151	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MAPK1—head and neck cancer	1.05e-05	0.000151	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.05e-05	0.000151	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—EGFR—head and neck cancer	1.05e-05	0.000151	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—PIK3CA—head and neck cancer	1.05e-05	0.000151	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MAPK1—head and neck cancer	1.05e-05	0.000151	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—EGFR—head and neck cancer	1.05e-05	0.000151	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MAPK1—head and neck cancer	1.05e-05	0.00015	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—EGFR—head and neck cancer	1.05e-05	0.00015	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MAPK1—head and neck cancer	1.04e-05	0.00015	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—EGFR—head and neck cancer	1.04e-05	0.00015	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MAPK1—head and neck cancer	1.03e-05	0.000148	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—EGFR—head and neck cancer	1.03e-05	0.000148	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TP53—head and neck cancer	1.02e-05	0.000146	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PTEN—head and neck cancer	9.75e-06	0.00014	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—HRAS—head and neck cancer	9.74e-06	0.00014	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PIK3CA—head and neck cancer	9.29e-06	0.000133	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PTEN—head and neck cancer	9.19e-06	0.000132	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PIK3CA—head and neck cancer	9.14e-06	0.000131	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PIK3CA—head and neck cancer	9.12e-06	0.000131	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PIK3CA—head and neck cancer	9.09e-06	0.00013	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PIK3CA—head and neck cancer	9.06e-06	0.00013	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TP53—head and neck cancer	8.99e-06	0.000129	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PIK3CA—head and neck cancer	8.97e-06	0.000129	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PTGS2—head and neck cancer	8.92e-06	0.000128	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—AKT1—head and neck cancer	8.85e-06	0.000127	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TP53—head and neck cancer	8.84e-06	0.000127	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TP53—head and neck cancer	8.82e-06	0.000126	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TP53—head and neck cancer	8.8e-06	0.000126	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TP53—head and neck cancer	8.77e-06	0.000126	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TP53—head and neck cancer	8.68e-06	0.000124	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—AKT1—head and neck cancer	8.6e-06	0.000123	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HRAS—head and neck cancer	8.59e-06	0.000123	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—HRAS—head and neck cancer	8.46e-06	0.000121	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HRAS—head and neck cancer	8.44e-06	0.000121	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HRAS—head and neck cancer	8.41e-06	0.000121	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HRAS—head and neck cancer	8.38e-06	0.00012	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HRAS—head and neck cancer	8.3e-06	0.000119	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PTEN—head and neck cancer	7.78e-06	0.000111	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—AKT1—head and neck cancer	7.59e-06	0.000109	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—AKT1—head and neck cancer	7.47e-06	0.000107	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—AKT1—head and neck cancer	7.45e-06	0.000107	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—AKT1—head and neck cancer	7.43e-06	0.000106	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—AKT1—head and neck cancer	7.4e-06	0.000106	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—AKT1—head and neck cancer	7.33e-06	0.000105	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PIK3CA—head and neck cancer	6.88e-06	9.85e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PIK3CA—head and neck cancer	6.48e-06	9.29e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—AKT1—head and neck cancer	5.62e-06	8.05e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PIK3CA—head and neck cancer	5.49e-06	7.87e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—AKT1—head and neck cancer	5.29e-06	7.59e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—AKT1—head and neck cancer	4.48e-06	6.43e-05	CbGpPWpGaD
